These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 16611118)

  • 1. Understanding helicases as a means of virus control.
    Frick DN; Lam AM
    Curr Pharm Des; 2006; 12(11):1315-38. PubMed ID: 16611118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicases as antiviral drug targets.
    Frick DN
    Drug News Perspect; 2003; 16(6):355-62. PubMed ID: 12973446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase.
    Adedeji AO; Singh K; Calcaterra NE; DeDiego ML; Enjuanes L; Weiss S; Sarafianos SG
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4718-28. PubMed ID: 22733076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicase-primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections.
    Biswas S; Sukla S; Field HJ
    Future Med Chem; 2014 Jan; 6(1):45-55. PubMed ID: 24358947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
    Yu MS; Lee J; Lee JM; Kim Y; Chin YW; Jee JG; Keum YS; Jeong YJ
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4049-54. PubMed ID: 22578462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovering new medicines targeting helicases: challenges and recent progress.
    Shadrick WR; Ndjomou J; Kolli R; Mukherjee S; Hanson AM; Frick DN
    J Biomol Screen; 2013 Aug; 18(7):761-81. PubMed ID: 23536547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of herpes simplex virus isolated from genital herpes lesions to ASP2151, a novel helicase-primase inhibitor.
    Katsumata K; Weinberg A; Chono K; Takakura S; Kontani T; Suzuki H
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3587-91. PubMed ID: 22526302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicase primase: targeting the Achilles heel of herpes simplex viruses.
    Kleymann G
    Antivir Chem Chemother; 2004 May; 15(3):135-40. PubMed ID: 15266895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.
    Mastrangelo E; Pezzullo M; De Burghgraeve T; Kaptein S; Pastorino B; Dallmeier K; de Lamballerie X; Neyts J; Hanson AM; Frick DN; Bolognesi M; Milani M
    J Antimicrob Chemother; 2012 Aug; 67(8):1884-94. PubMed ID: 22535622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent primuline derivatives inhibit hepatitis C virus NS3-catalyzed RNA unwinding, peptide hydrolysis and viral replicase formation.
    Ndjomou J; Kolli R; Mukherjee S; Shadrick WR; Hanson AM; Sweeney NL; Bartczak D; Li K; Frankowski KJ; Schoenen FJ; Frick DN
    Antiviral Res; 2012 Nov; 96(2):245-55. PubMed ID: 22940425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ring-expanded ("fat") nucleoside and nucleotide analogues exhibit potent in vitro activity against flaviviridae NTPases/helicases, including those of the West Nile virus, hepatitis C virus, and Japanese encephalitis virus.
    Zhang N; Chen HM; Koch V; Schmitz H; Liao CL; Bretner M; Bhadti VS; Fattom AI; Naso RB; Hosmane RS; Borowski P
    J Med Chem; 2003 Sep; 46(19):4149-64. PubMed ID: 12954067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of chemical inhibitors of the SARS coronavirus: viral helicase as a potential target.
    Keum YS; Jeong YJ
    Biochem Pharmacol; 2012 Nov; 84(10):1351-8. PubMed ID: 22935448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus.
    Field HJ; Biswas S
    Drug Resist Updat; 2011 Feb; 14(1):45-51. PubMed ID: 21183396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
    Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
    J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target.
    Frick DN
    Curr Issues Mol Biol; 2007 Jan; 9(1):1-20. PubMed ID: 17263143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism and specificity of a symmetrical benzimidazolephenylcarboxamide helicase inhibitor.
    Belon CA; High YD; Lin TI; Pauwels F; Frick DN
    Biochemistry; 2010 Mar; 49(9):1822-32. PubMed ID: 20108979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.
    Crute JJ; Grygon CA; Hargrave KD; Simoneau B; Faucher AM; Bolger G; Kibler P; Liuzzi M; Cordingley MG
    Nat Med; 2002 Apr; 8(4):386-91. PubMed ID: 11927945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A short commentary on the review by Weller and Kuchta: the DNA helicase-primase complex as a target for herpes virus infection.
    Field HJ
    Expert Opin Ther Targets; 2013 Oct; 17(10):1113-4. PubMed ID: 24044544
    [No Abstract]   [Full Text] [Related]  

  • 19. Helicases as antiviral and anticancer drug targets.
    Xi XG
    Curr Med Chem; 2007; 14(8):883-915. PubMed ID: 17430143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High conservation of herpes simplex virus UL5/UL52 helicase-primase complex in the era of new antiviral therapies.
    Collot M; Rouard C; Brunet C; Agut H; Boutolleau D; Burrel S
    Antiviral Res; 2016 Apr; 128():1-6. PubMed ID: 26826441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.